ea0083ao1 | Adrenal and Cardiovascular | EYES2022
M Parasiliti-Caprino
, C Rosso
, F Ponzetto
, P Caviglia G.
, C Lopez
, A Armandi
, G. M. Saracco
, E Ghigo
, E Bugianesi
, M Maccario
Introduction: The onset and progression of liver damage in non-alcoholic fatty liver disease (NAFLD) is tightly associated with metabolic derangements. Steroids may affect lipid metabolism but their alterations in the setting of NAFLD remain to be fully explored.Patients and Methods: We analyzed data from 267 patients with biopsy-proven NAFLD and 112 controls (CT). A panel of 26 steroids (including glucocorticoids, mineralocorticoids, androgens, and prog...